FDA Grants 510(k) Clearance for Pulmera’s CBeam™ 3D Imaging Platform
CBeam by Pulmera transforms existing C-arm infrastructure into scalable intraoperative3D imaging PALO ALTO, Calif., June 2, 2026 — Pulmera, an emerging medical technology company developing next-generation intraoperative imaging solutions, today announced that it has received U.S. Food and Drug Administration 510(k) clearance for its CBeam™ 3D imaging platform. CBeam is designed to transform conventional 2D […]
